Society Logo
ME/CFS Australia Ltd
Please Click Here To Donate ME/CFS Australia (SA) Inc
Become a Member
PDF Application Form 2015 (PDF, 243KB)
Text Application Form 2015 (plain text)
Why become a member?


Registered Charity 698


Mailing address:
PO Box 28,
South Australia 5007

266 Port Road,
South Australia 5007
Ph: 1300 128 339

Office Hours:
Wednesdays, 10am-3pm

Fibromyalgia SA
at the
Arthritis Foundation of SA
118 Richmond Road,
Marleston 5033
Ph: (08) 8379 5711

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.


Eco Pest Control

ME/CFS Australia (SA) Inc wishes to thank Eco Pest Control for its support of the Society.

BankSA & Staff Charitable Fund

ME/CFS Australia (SA) Inc wishes to thank BankSA & Staff Charitable Fund for its support of Talking Point, the Society’s official journal.

Society Seminars for 2016
Saturday 20 February 2016

Saturday 9 April 2016

Saturday 25 June 2016

Saturday 27 August 2016

Saturday 19 November 2016
Annual General Meeting

ME/CFS Diagnostic Criteria and Guidelines

www ME: International Consensus Criteria
(Journal of Internal Medicine, Aug 2011)

For GPs:
ME – Adult & Paediatric:
International Consensus Primer for Medical Practitioners
(PDF, 1.49 MB)


ME/CFS: A Clinical Case Definition and Guidelines for Medical Practitioners
– An Overview of the Canadian Consensus Document
(PDF, 1 MB)

  Note: See here for an overview on the Canadian Consensus Criteria for Fibromyalgia (PDF, 1.70 MB)


ME/CFS Guidelines for GPs
(South Australian Department of Health)
(English) (PDF, 460 KB)


ME/CFS Guidelines for GPs
(South Australian Department of Health)
(German) (PDF, 186 KB)


For Psychiatrists (in English):
CFS: Assessment and Treatment of Patients with ME/CFS – Clinical Guidelines for Psychiatrists
(Eleanor Stein MD FRCP[C], 2005)
(PDF, 460 KB)


For Psychiatrists (in German):
Chronic Fatigue Syndrom: Diagnose und Behandlung von Patienten mit ME/CFS – Klinische Leitlinien für Psychiater
(Eleanor Stein MD FRCP[C], 2005)
(PDF, 313 KB)

Australian ME/CFS Societies
ME/CFS Australia Ltd
Address: PO Box 7100 Dandenong VIC 3175
Phone: (03) 9793 4500
Fax: (03) 9793 1866
ACT ME/CFS Society, Inc
Address: c/o SHOUT, PO Box 717, Mawson ACT 2607
Phone: (02) 6290 1984
Fax: (02) 6290 4475
ME/CFS Society of NSW Inc
Postal address: PO Box 5403, West Chatswood NSW 1515
Office address: Suite 204, 10 Help Street, Chatswood NSW 2067
Phone: (02) 8006 7448
The ME/CFS & FM Association NSW
Facebook: ME/CFS & FM NSW Support Group
Facebook: Chronic Fatigue Syndrome NSW
ME/CFS Australia (Northern Territory)
Address: PO Box 120, Prahran, VIC 3181
Reception: (03) 9529 1344
Support Line: (03) 9529 1600
ME/CFS/FM Support Association Qld Inc
Address: c/o Mission Department, St. Vincent’s Hospital, Toowoomba Qld 4350
Phone: (07) 4632 8173
Facebook Page
ME/CFS Australia (SA) Inc
Postal address: PO Box 28, Hindmarsh SA 5007
Address: 266 Port Road, Hindmarsh SA 5007
Phone: (08) 8346 3237 ('834 MECFS')
Support line: (08) 8346 3237 or 1300 128 339 for country callers
ME/CFS Australia (Tasmania)
Address: PO Box 120, Prahran, VIC 3181
Reception: (03) 9529 1344
Support Line: (03) 9529 1600
ME/CFS Australia (Victoria)
Office address: 2/240 Chapel Street, Prahran, VIC, 3181
Postal address: PO Box 120, Prahran, VIC 3181
Reception: (03) 9529 1344
Support Line: (03) 9529 1600
The ME/CFS Society of WA (Inc)
Address: The Centre for Neurological Support, The Niche, 11 Aberdare Road, Nedlands, Perth WA 6009
Phone: (08) 9346 7477
Fax: (08) 9346 7534


List of Australian ME/CFS organisations
(PDF, 19 KB)


List of Australian ME/CFS organisations (Word, 41 KB)



No Dissing! NHS Choices 'Behind The Headlines' Needs To Repair Relationship With Its Readers

International news

Monday 30 November 2015


From James C Coyne:

NHS Choices

No Dissing! NHS Choices Behind the Headlines needs to repair relationship with its readers

James C Coyne
November 29, 2015

Although by no means perfectly dependable, the NHS Choices Behind the Headlines is generally a useful resource for lay and professional consumers bombarded by distorted coverage of science and health information in the media.

I cheered the headline and NHS Choices Behind the Headlines’ coverage of a PLOS Medicine article

Half of medical reporting ‘is subject to spin’

According to its website

NHS Choices Behind the Headlines

Is intended for both the public and health professionals, and endeavours to:

• explain the facts behind the headlines and give a better understanding of the science that makes the news,
• provide an authoritative resource for GPs that they can rely on when talking to patients, and
• become a trusted resource for journalists and others involved in the dissemination of health news.

Read more…


FDA Says Some Lyme Disease Tests Are Dangerous

International news

Sunday 29 November 2015


From Health Rising Forums:

FDA logo

FDA Says Some Lyme Tests are Dangerous - Will Start Regulating Them - Major Changes Expected

Posted on November 27, 2015

Last November the FDA stated it was going to start regulating what it calls "Laboratory Developed Tests". These are tests that are developed by and for single laboratories (often genomic firms) but have not been subjected to regulatory approval. At the time the FDA's regulation was created these tests were rare but with the development of genomic testing thousands have been developed. Many labs do subject their tests to stringent internal and/or independent testing but not all do.

That announcement was met by fierce opposition by industry and some academics.They stated the new regulations - which will likely make tests more expensive to develop - would stifle innovation and hurt patients.

The FDA, however, believes some of these tests are doing more harm than good.

In some cases, due to false-positive tests, patients were told they have conditions they do not really have, causing unnecessary distress and resulting in unneeded treatment. In other cases, the LDTs were prone to false-negative results, in which patients’ life-threatening diseases went undetected. As a result, patients failed to receive effective treatments.

Read more…


Medical Marijuana Great For Migraine, Fibromyalgia And Irritable Bowel Syndrome, Survey Finds

International news

Saturday 28 November 2015


From the National Pain Report:


Medical Marijuana Great for Migraine, Fibromyalgia and Irritable Bowel Syndrome, Survey Finds

Posted on November 27, 2015

One-hundred percent (100%) of people with migraine headache, fibromyalgia or irritable bowel syndrome who use medical marijuana for a minimum of 30 days report a reduction in pain and discomfort, a survey of 621 by the Care By Design found.

People included in the survey suffer from a range of different conditions, and some suffer from multiple conditions, including:

  • Psychiatric disorders (24%)
    • Anxiety, PTSD, depression, autism, addiction
  • Inflammatory conditions (19%)
    • Arthritis, rheumatism, Crohn’s disease, irritable bowel syndrome
  • Pain (14%)
    • Neuropathic pain, headaches, migraines, fibromyalgia
  • Central nervous system disorders (12%)
    • Multiple sclerosis, epilepsy, spinal cord injury, Parkinson’s, Traumatic Brain Injury (TBI)
  • Cancer-related symptoms (12%)

Cannabis and Well-Being

“A majority of patients (88.2%) reported that cannabis therapy improved their overall sense of wellbeing,” the study found. “Patients with fibromyalgia, headaches and migraines, PTSD and anxiety reported the greatest improvement in general wellbeing (as compared to other patient groups).”

Read more…


Queen Mary University Of London To Appeal Information Commissioner's Decision On Disclosure Of PACE Trial Data

International news

Friday 27 November 2015


From the blog of UK lawyer and ME/CFS sufferer Valerie Eliot Smith:

Queen Mary University of London

Queen Mary University of London to appeal Information Commissioner’s decision on disclosure of PACE Trial data

Valerie Eliot Smith
November 26, 2015


I have lived with the illness myalgic encephalomyelitis (ME) for nearly 35 years. The condition is also (misleadingly) known as “Chronic Fatigue Syndrome” and is therefore often referred to as “ME/CFS” or “CFS/ME”. For more information see “About”.

I have previously written about the controversial PACE Trial (Principal Investigator: Professor Peter White of St Bartholomew’s Hospital in London) and its highly questionable effects on the treatment of patients – see PACE vs FOIA: Access Denied.

The current case

Ever since the results of this £5 million (US$8m) publicly-funded trial were published by The Lancet in 2011, patients have been attempting to gain access to the trial data as the results were spun in a surprisingly positive light. In 2014, I made a request under the Freedom of Information Act (FOIA) to ascertain the number of requests which had been made in total. The answer wasn’t clear but the figure seemed to be well in excess of 150. However, very little data has been released so far and patient groups are still puzzled by how the results have continued to be framed in such positive terms.

Professor White has also used patients’ efforts to access trial information as a vehicle to make spurious claims of harassment against members of the PACE team and a “campaign to discredit the trial”.

Read more…


Carl-Gerhard Gottfries: A Swedish Chronic Fatigue Syndrome Story

International news

Friday 27 November 2015


From Health Rising:

Against the flow

Carl-Gerhard Gottfries: A Swedish Chronic Fatigue Syndrome Story

Nov 21, 2015

“These are really…immunological disorders” Dr. Carl-Gerhard Gottfries (psychiatrist)

It’s a fascinating story. It involves a psychiatrist who over fifty years ago cured his chronic fatigue syndrome using an immune booster. When he was barred from treating others in the clinic with it he resumed his psychiatric work but never stopped thinking about it. Thirty years later he used the same agent to successfully help many people with ME/CFS in an ME/CFS clinic in small town on the west coast of Sweden.

His names is Dr. Carl-Gerhard Gottfries. He’s the founder of the Gottfries Clinic in Sweden. He became interested in ME/CFS and FM almost fifty years ago after the Asian Flu epidemic of 1957/8 ravaged Sweden leaving some with severe and long lasting post-infectious fatigue. When doctors couldn’t explain what was going on with these patients, they were sent, of course, to his psychiatric clinic.

Gottfrie’s detailed examinations of over a hundred patients, however, uncovered no signs of a psychiatric disorder. He might have left it at that – another medical mystery – but then he caught the flu.

Gottfries was in bed for a week – that was normal – but then like his patients he had trouble recovering. Convinced that some of the infection must remain Gottfries began attempting to boost his immune system. In the late 1950’s he didn’t have many options and so he began a course that many today would find frightening – he began poking himself with vaccines.

It took him three years but eventually Gottfries found that a staphylococcus aureus vaccine (Staphypan Berna (Berna Biotech, Switzerland) containing a mixture of staphylococcus strains and a toxoid worked, and his fatigue went away. When his superiors balked treating patients at their psychiatric clinic with vaccines Gottfries returned to his focus on dementia and other diseases.

Read more…


Visual Stress Could Be A Symptom Of Chronic Fatigue Syndrome, Research Suggests

International news

Thursday 26 November 2015


From Medical Xpress:

(Credit: George Hodan/
public domain

Visual stress could be a symptom of chronic fatigue syndrome, research suggests

November 24, 2015

People suffering from chronic fatigue syndrome (CFS) could experience higher levels of visual stress than those without the condition, according to new research from the University of Leicester.

CFS, also known as myalgic encephalomyelitis (ME), is a condition that causes persistent exhaustion that affects everyday life and doesn't go away with sleep or rest. Diagnosis of the condition is difficult as its symptoms are similar to other illnesses.

A research team from the University of Leicester led by Dr Claire Hutchinson from the Department of Neuroscience, Psychology and Behaviour has examined patients with and without CFS and has found that those suffering from the condition are more vulnerable to pattern-related visual stress, which causes discomfort and exhaustion when viewing repetitive striped patterns, such as when reading text.

The results of the study, which is published in the journal Perception, could help in the diagnosis of CFS, as the findings suggest that there are visual system abnormalities in people with ME/CFS that may represent an identifiable and easily measurable behavioural marker of the condition.

Read more…


'Nostalgia' Art Exhibit Brings To Life Visual Representations Of The Past

International news

Wednesday 25 November 2015


From Canadian newspaper The Journal Pioneer:

Eddy Schwartz and Bernadette Kernaghan
Eddy Schwartz (left), an artist
himself was the inspiration for
the oil painting, “The Captain,”
which was done by his wife
Bernadette Kernaghan (right).
(© Desiree Anstey/Journal Pioneer)

'Nostalgia' art exhibit brings to life visual representations of the past

Desiree Anstey
Published on November 22, 2015

The Summerside Art Club has taken over the Eptek Centre with an all-new show, entitled “Nostalgia,” bringing to life memories and interpretations of artists in a dazzling display.

Liana Brittain, a member of the club, suffers from Fibromyalgia, a complex chronic pain disorder that affects her physically, mentally and socially.

She discovered “zentangle” as a therapeutic way to relax and intentionally facilitate a shift in focus and perspective.

“Zentangle was formed when a yoga instructor and artist combined their abilities to create a healing experience,” explained Brittain. “So I adopted this style of artwork in order to help maintain my Fibromyalgia (at a lower level) and how much chronic pain I experience at a time.”

Intricate patterns are drawn by Brittain and then coloured and shaded to create a three-dimensional effect. Her watercolour painting, entitled “Once Upon a Time,” represents a page in a child’s fairy-tale book.

“It’s a good therapeutic experience,” she added. “And it took me around two or three weeks to complete.”

Read more…


Sleep Improvement For Fibromyalgia Sufferers Possible, Study Shows

International news

Wednesday 25 November 2015


From National Pain Report:


Sleep Improvement for Fibromyalgia Sufferers Possible, Study Shows

Posted on November 23, 2015

A new drug being tested in clinical trials to treat fibromyalgia, called Tonmya, is showing promise for sleep improvement and pain reduction.

Tonmya is being evaluated in the 500-patient Phase 3 AFFIRM study in fibromyalgia. The primary outcome measure for this study is a pain responder analysis, which basically means patients report a minimum of a 30% reduction in pain from their baseline after undergoing treatments for 12 weeks.

The drug is taken at night daily, and researchers are seeing that patients are seeing improvements in sleep.

“Our new analyses of the BESTFIT data show that those patients who reported the greatest improvement in sleep quality were the most likely to experience pain relief,” said Seth Lederman, M.D., Tonix’s chairman and CEO. “We also observed that the group treated with Tonmya was approximately twice as likely as placebo-treated patients to be in the top third of reported sleep quality improvement. Among all patients in BESTFIT who ranked highest in reported sleep quality improvement, twice as many Tonmya-treated patients experienced at least a 30% improvement in their pain as compared to those treated with placebo.”

Read more…


Professor James Coyne Declares "Moral Equivalent Of War" On PACE

International news

Tuesday 24 November 2015


From #ME Action:

Professor James Coyne
Professor James Coyne


By #ME Action
November 18, 2015

In a public talk in Edinburgh on Monday [16 November 2015], psychologist Professor James Coyne declared the “moral equivalent of war” on the practices and assumptions that, he said, have allowed the “bad science” of the PACE trial to go unchallenged by scientists and the media.

The authors of the UK’s £5 million PACE trial have claimed that it showed that cognitive behavioural therapy and graded exercise therapy were beneficial for patients with chronic fatigue syndrome. Patients have criticised the trial’s methodology since its publication but criticisms have been dismissed by the study authors as reflecting “the apparent campaign to bring the robust findings of the trial into question.”

Professor Coyne’s attention was drawn to PACE by the authors’ latest claims, made in a recent Lancet Psychiatry paper, that long-term follow-up of patients confirmed these benefits. Coyne published a detailed blog post condemning the paper as “uninterpretable” and as having used “voodoo statistics” in a failed attempt to correct for “fatal flaws.”

Read more…


For previous news items, visit our full “In the News” archive:

In the News

Home | Welcome | In the News | ME/CFS Australia (Victoria) | The Society | Society Management | Become a member | Events | About ME/CFS | Resources | Publications | Medical | Links | Multimedia | Humour | My favourite… | Contact the Society | Volunteer positions
Copyright © ME/CFS Australia (SA) Inc
Site maintained by Peter Scott
Last modified: November 30, 2015